RENAL SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR WITH HEPATITIS B IMMUNOGLOBULIN IN LIVER TRANSPLANT PATIENTS

被引：0
|
作者：
Lee, Juhan [1 ]
Park, Jun Yong [2 ]
Yang, Seok Jeong [1 ]
Lee, Jee Youn [3 ]
Kim, Deok Gie [4 ]
Joo, Dong Jin [1 ]
Kim, Myoung Soo [1 ]
Kim, Soon Il [1 ]
Lee, Jae Geun [1 ]
机构：
[1] Yonsei Univ, Surg, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Internal Med, Coll Med, Seoul, South Korea
[3] Gangbuk Samsung Med Ctr, Surg, Seoul, South Korea
[4] Wonju Severance Christian Hosp, Surg, Wonju, South Korea
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-12.106
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [31] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients with cirrhosis
    Liu, Ken
    Choi, Jonggi
    Le, An
    Wong, Vincent Wai-Sun
    Chan, Stephen L.
    Nguyen, Mindie
    Lim, Young-Suk
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E475 - E476
  • [32] Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients
    Tsai, H. J.
    Chuang, Y. W.
    Lee, S. W.
    Wu, C. Y.
    Yeh, H. Z.
    Lee, T. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (12) : 1673 - 1681
  • [33] Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis
    Liu, Zekun
    Zhao, Zhenzhen
    Ma, Xuefeng
    Liu, Shousheng
    Xin, Yongning
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [34] THE EFFECTS OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE, AND TENOFOVIR ALAFENAMIDE ON THE PROGNOSIS OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONS
    Chon, Hye Yeon
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Kim, Seung Up
    HEPATOLOGY, 2020, 72 : 498A - 498A
  • [35] EFFECTIVENESS AND SAFETY OF SWITCHING TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR TO TENOFOVIR ALAFENAMIDE FUMARATE ( TAF) IN VIROLOGICALLY SUPPRESSED CHRONIC HEPATITIS B VIRUSINFECTED PATIENTS WITH ONEMINUTE OSTEOPOROSIS RISK TEST
    Li, Hui
    Li, Chunmei
    Wei, Jia
    Liu, Yunhua
    Gong, Ming
    Zhang, Ruyi
    Geng, Jiawei
    Wang, Hongyan
    Yu, Zhijian
    Wang, Zi
    Liu, Xiang
    HEPATOLOGY, 2023, 78 : S513 - S513
  • [36] Tenofovir Disoproxil Fumarate In Chronic Hepatitis B
    Perry, Caroline M.
    Simpson, Dene
    DRUGS, 2009, 69 (16) : 2245 - 2256
  • [37] Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis
    Zekun Liu
    Zhenzhen Zhao
    Xuefeng Ma
    Shousheng Liu
    Yongning Xin
    BMC Gastroenterology, 23
  • [38] Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study
    Ha, Nghi B.
    Ku, Kevin
    Ha, Nghiem B.
    Chaung, Kevin T.
    Trinh, Huy N.
    Nguyen, Mindie H.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (10) : 873 - 877
  • [39] Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation
    Lin, Chih-Yang
    Sun, Wei-Chih
    Lu, Chia-Ming
    Chen, Wen-Chi
    Tsay, Feng-Woei
    Tsai, Tzun-Jiun
    Kuo, Feng-Yu
    Tsai, Wei-Lun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (09) : 1113 - 1118
  • [40] INTERIM RESULTS OF A DOUBLE-BLIND, RANDOMIZED PHASE 2 STUDY OF THE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE PLUS TENOFOVIR DISOPROXIL FUMARATE, AND ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B SUBJECTS WITH DECOMPENSATED LIVER DISEASE
    Liaw, Yun-Fan
    Lee, Chuan-Mo
    Akarca, Ulus S.
    George, Papatheodoridis V.
    Wong, Florence
    Chang, Ting-Tsung
    Horban, Andrzej
    Wang, Chia C.
    Kwan, Peter
    Buti, Maria
    Prieto, Martin
    Berg, Thomas
    Kitrinos, Kathryn M.
    Sorbel, Jeff
    Mondou, Elsa
    Frederick, David
    Rousseau, Franck
    Schiff, Eugene R.
    HEPATOLOGY, 2009, 50 (04) : 409A - 410A
12345